Atossa Therapeutics, Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

5.11

-0.15 (-2.85%)

At close: Apr 1, 2026, 4:00 PM EDT

5.00

-0.11 (-2.15%)

After-hours: Apr 1, 2026, 6:46 PM EDT

Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.3	71.08	88.46	110.89	136.38
Cash & Short-Term Investments	41.3	71.08	88.46	110.89	136.38
Cash Growth	-41.90%	-19.64%	-20.23%	-18.69%	244.79%
Other Receivables	-	-	-	0.74	1.07
Total Trade Receivables	-	-	-	0.74	1.07
Other Current Assets	4.32	3.37	3.76	6.56	3.79
Total Current Assets	45.62	74.46	92.22	118.2	141.24
Long-Term Investments	-	-	1.71	4.7	-
Other Long-Term Assets	1.99	1.99	2.32	0.64	0.02
Total Assets	47.61	76.44	96.25	123.53	141.26
Accounts Payable	4.29	0.68	0.81	2.97	1.72
Accrued Expenses	2.87	2.78	2.63	2.58	1.39
Other Current Liabilities	1.1	1.51	1.8	0.02	0.02
Total Current Liabilities	8.26	4.97	5.24	5.57	3.13
Total Liabilities	8.26	4.97	5.24	5.57	3.13
Common Stock	1.55	1.55	22.79	22.79	22.79
Treasury Stock	-1.48	-1.48	-1.48	-	-
Additional Paid-in Capital	285.84	283.19	255.99	251.37	244.58
Retained Earnings	-246.56	-211.79	-186.29	-156.19	-129.23
Shareholders' Equity	39.35	71.48	91.02	117.96	138.14
Total Liabilities & Equity	47.61	76.44	96.25	123.53	141.26
Net Cash (Debt)	41.3	71.08	88.46	110.89	136.38
Net Cash Growth	-41.90%	-19.64%	-20.23%	-18.69%	244.94%
Net Cash Per Share	4.80	8.47	10.52	13.14	17.49
Book Value	39.35	71.48	91.02	117.96	138.14
Book Value Per Share	4.57	8.52	10.83	13.97	17.72
Tangible Book Value	39.35	71.48	91.02	117.96	138.14
Tangible Book Value Per Share	4.57	8.52	10.83	13.97	17.72

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q